Literature DB >> 25921841

High circulating adiponectin levels predict decreased muscle strength among older adults aged 70 years and over: A prospective cohort study.

C Huang1, Y Tomata2, M Kakizaki2, Y Sugawara2, A Hozawa3, H Momma4, I Tsuji2, R Nagatomi5.   

Abstract

BACKGROUND AND AIMS: Population-based researches indicate that circulating adiponectin is inversely associated with muscle strength. However, interpretation of the findings has been limited by the use of a cross-sectional design. This study aimed to examine the prospective relationship between baseline circulating adiponectin concentration and change in muscular function-related physical performance in older adults. METHODS AND
RESULTS: A 1-year prospective cohort study of Japanese community-dwelling elderly was conducted between 2002 and 2003. Four hundred thirty-four older persons participated in the measurements of physical function, including leg extension power, functional reach, timed up-and-go test, and 10-m maximum walking speed, at baseline and follow-up. After adjustment for potential covariates, higher serum adiponectin concentration was found to be significantly associated with poorer physical performance at baseline (leg extension power [watt], P < 0.001; functional reach [cm], P < 0.001; log timed up-and-go test, P = 0.007; log 10-m maximum walking speed, P < 0.001). The results of the prospective analysis by analysis of covariance indicated that the elderly with higher serum adiponectin concentrations (tertiles) at baseline tended to have a decreased performance in leg extension power (means [95% confidence interval]: lowest, -105 [-125, -85.7]; middle, -117 [-135, -97.8]; highest, -140 [-160, -120], watt, P for trend = 0.021) and timed up-and-go test (lowest, -0.08 [-0.28, -0.12]; middle, -0.10 [-0.29, 0.10]; highest, 0.28 [0.07, 0.48], s, P for trend = 0.019), but not two other functioning.
CONCLUSION: High circulating adiponectin concentration may be an indicator of decreased physical performance, especially muscle strength, in older adults.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipokine; Aging; Physical function; Sarcopenia

Mesh:

Substances:

Year:  2015        PMID: 25921841     DOI: 10.1016/j.numecd.2015.03.010

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  12 in total

1.  Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry.

Authors:  Yuji Komorita; Masanori Iwase; Hiroki Fujii; Toshiaki Ohkuma; Hitoshi Ide; Tamaki Jodai-Kitamura; Akiko Sumi; Masahito Yoshinari; Udai Nakamura; Dongchon Kang; Takanari Kitazono
Journal:  Diabetologia       Date:  2017-07-18       Impact factor: 10.122

2.  High serum adiponectin levels predict incident falls among middle-aged and older adults: a prospective cohort study.

Authors:  Cong Huang; Haruki Momma; Kaijun Niu; Masahiko Chujo; Atsushi Otomo; Yufei Cui; Ryoichi Nagatomi
Journal:  Age Ageing       Date:  2016-03-23       Impact factor: 10.668

3.  New diagnostic index for sarcopenia in patients with cardiovascular diseases.

Authors:  Haruhito Harada; Hisashi Kai; Rei Shibata; Hiroshi Niiyama; Yasuhiro Nishiyama; Toyoaki Murohara; Noriko Yoshida; Atsushi Katoh; Hisao Ikeda
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

4.  Long-term retrospective observation study to evaluate effects of adiponectin on skeletal muscle in renal transplant recipients.

Authors:  Hiroki Adachi; Keiji Fujimoto; Ai Fujii; Keita Yamasaki; Keiichiro Okada; Toshikazu Matsuura; Kazuaki Okino; Kengo Furuichi; Hitoshi Yokoyama
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

5.  Associations of Abdominal Muscle Area and Radiodensity with Adiponectin and Leptin: The Multiethnic Study of Atherosclerosis.

Authors:  Chantal A Vella; Mary Cushman; Rachel B Van Hollebeke; Matthew A Allison
Journal:  Obesity (Silver Spring)       Date:  2018-06-07       Impact factor: 5.002

6.  Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention.

Authors:  Chun-Wei Li; Kang Yu; Ng Shyh-Chang; Guo-Xun Li; Ling-Juan Jiang; Song-Lin Yu; Long-Yu Xu; Rong-Ji Liu; Zi-Jian Guo; Hai-Yan Xie; Rong-Rong Li; Jie Ying; Kang Li; Dong-Jing Li
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-04-10       Impact factor: 12.910

7.  Association of serum adiponectin and myostatin levels with skeletal muscle in patients with obesity: A cross-sectional study.

Authors:  Satoshi Kurose; Katsuko Onishi; Nana Takao; Takumi Miyauchi; Kazuhisa Takahashi; Yutaka Kimura
Journal:  PLoS One       Date:  2021-01-19       Impact factor: 3.240

8.  Sarcopenia and Appendicular Muscle Mass as Predictors of Impaired Fasting Glucose/Type 2 Diabetes in Elderly Women.

Authors:  Carola Buscemi; Yvelise Ferro; Roberta Pujia; Elisa Mazza; Giada Boragina; Angela Sciacqua; Salvatore Piro; Arturo Pujia; Giorgio Sesti; Silvio Buscemi; Tiziana Montalcini
Journal:  Nutrients       Date:  2021-06-02       Impact factor: 5.717

9.  The relationship between changes in serum myostatin and adiponectin levels in patients with obesity undergoing a weight loss program.

Authors:  Nana Takao; Satoshi Kurose; Takumi Miyauchi; Katsuko Onishi; Atsuko Tamanoi; Ryota Tsuyuguchi; Aya Fujii; Sawako Yoshiuchi; Kazuhisa Takahashi; Hiromi Tsutsumi; Yutaka Kimura
Journal:  BMC Endocr Disord       Date:  2021-07-08       Impact factor: 2.763

10.  Activation of adiponectin receptors has negative impact on muscle mass in C2C12 myotubes and fast-type mouse skeletal muscle.

Authors:  Rika Ito; Masaki Higa; Ayumi Goto; Megumi Aoshima; Akihiro Ikuta; Kazuya Ohashi; Shingo Yokoyama; Yoshitaka Ohno; Tatsuro Egawa; Hirofumi Miyata; Katsumasa Goto
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.